203 related articles for article (PubMed ID: 30465163)
1. Modified Genomic Self-DNA Influences In Vitro Survival of HT29 Tumor Cells via TLR9- and Autophagy Signaling.
Sipos F; Kiss AL; Constantinovits M; Tulassay Z; Műzes G
Pathol Oncol Res; 2019 Oct; 25(4):1505-1517. PubMed ID: 30465163
[TBL] [Abstract][Full Text] [Related]
2. Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response.
Bohusné Barta B; Simon Á; Nagy L; Dankó T; Raffay RE; Petővári G; Zsiros V; Sebestyén A; Sipos F; Műzes G
PLoS One; 2022; 17(5):e0268217. PubMed ID: 35551547
[TBL] [Abstract][Full Text] [Related]
3. Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition
Sipos F; Bohusné Barta B; Simon Á; Nagy L; Dankó T; Raffay RE; Petővári G; Zsiros V; Wichmann B; Sebestyén A; Műzes G
Pathol Oncol Res; 2022; 28():1610322. PubMed ID: 35651701
[No Abstract] [Full Text] [Related]
4. Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-cells to DNA fragment length and methylation status.
Fűri I; Sipos F; Spisák S; Kiszner G; Wichmann B; Schöller A; Tulassay Z; Műzes G; Molnár B
ScientificWorldJournal; 2013; 2013():293296. PubMed ID: 24459426
[TBL] [Abstract][Full Text] [Related]
5. Cell-free DNA-induced alteration of autophagy response and TLR9-signaling: Their relation to amelioration of DSS-colitis.
Műzes G; Kiss AL; Tulassay Z; Sipos F
Comp Immunol Microbiol Infect Dis; 2017 Jun; 52():48-57. PubMed ID: 28673462
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
Niu Z; Tang W; Liu T; Xu P; Zhu D; Ji M; Huang W; Ren L; Wei Y; Xu J
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1007-1017. PubMed ID: 30239551
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
8. Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line.
Fűri I; Kalmár A; Wichmann B; Spisák S; Schöller A; Barták B; Tulassay Z; Molnár B
PLoS One; 2015; 10(7):e0131699. PubMed ID: 26133168
[TBL] [Abstract][Full Text] [Related]
9. Combination of targeting CD24 and inhibiting autophagy suppresses the proliferation and enhances the apoptosis of colorectal cancer cells.
Zhuo J; Wang X
Mol Med Rep; 2019 Jul; 20(1):539-548. PubMed ID: 31180548
[TBL] [Abstract][Full Text] [Related]
10. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.
Ewaschuk JB; Backer JL; Churchill TA; Obermeier F; Krause DO; Madsen KL
Infect Immun; 2007 May; 75(5):2572-9. PubMed ID: 17325049
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
[TBL] [Abstract][Full Text] [Related]
12. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
[TBL] [Abstract][Full Text] [Related]
13. TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.
Gao C; Kozlowska A; Nechaev S; Li H; Zhang Q; Hossain DM; Kowolik CM; Chu P; Swiderski P; Diamond DJ; Pal SK; Raubitschek A; Kortylewski M
Cancer Res; 2013 Dec; 73(24):7211-21. PubMed ID: 24154870
[TBL] [Abstract][Full Text] [Related]
14. Effect of light irradiation by light emitting diode on colon cancer cells.
Matsumoto N; Yoshikawa K; Shimada M; Kurita N; Sato H; Iwata T; Higashijima J; Chikakiyo M; Nishi M; Kashihara H; Takasu C; Eto S; Takahashi A; Akutagawa M; Emoto T
Anticancer Res; 2014 Sep; 34(9):4709-16. PubMed ID: 25202048
[TBL] [Abstract][Full Text] [Related]
15. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
16. Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines.
Shahriari S; Rezaeifard S; Moghimi HR; Khorramizadeh MR; Faghih Z
Cancer Biomark; 2017; 18(4):375-380. PubMed ID: 28106541
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
18. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
[TBL] [Abstract][Full Text] [Related]
19. Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy.
Anunobi R; Boone BA; Cheh N; Tang D; Kang R; Loux T; Lotze MT; Zeh HJ
J Surg Res; 2018 Jun; 226():181-191. PubMed ID: 29605400
[TBL] [Abstract][Full Text] [Related]
20. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
